At the American Society of Nephrology’s Kidney Week meeting, researchers identified a new signal that predicts kidney transplant rejection, potentially leading to earlier intervention for improved patient outcomes.
Despite achieving a 33.8% implementation rate of its recommendations versus 24.3% in usual care, a novel kidney action team intervention failed to improve outcomes in 4,003 hospitalized patients with acute kidney injury - highlighting the complex challenge of translating increased diagnostic testing into better clinical results.
A recent study unveils the lasting protective effects of empagliflozin on the kidneys and the heart, emphasizing the need for long-term treatment to maximize benefits. Further details in the report published in The New England Journal of Medicine.